Kaiser Permanente Addiction Medicine Department

Kaiser Permanente Addiction Medicine Department

Services:
Facility Vaping Policy
• Vaping not permitted

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Intensive outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient detoxification
• Outpatient
• Regular outpatient treatment
• Outpatient day treatment or partial hospitalization

Other Services

• Treatment for other addiction disorder
• Treatment for gambling disorder

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Outcome follow-up after discharge
• Aftercare/continuing care

Facility Smoking Policy

• Smoking not permitted

Gender Accepted

• Female
• Male

Testing

• Testing for Hepatitis C (HCV)
• HIV testing
• STD testing
• Breathalyzer or blood alcohol testing
• Metabolic syndrome monitoring
• Testing for Hepatitis B (HBV)

Detoxification (medical withdrawal) Services

• Benzodiazepines Detoxification
• Cocaine Detoxification
• Alcohol Detoxification
• Methamphetamines detoxification
• Medication routinely used during detoxification
• Opioids detoxification

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine detoxification
• Lofexidine or Clonidine detoxification
• Relapse prevention with naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Buprenorphine maintenance
• Prescribes buprenorphine

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders
• Adolescents

Ancillary Services

• Mental health services
• Case management service

Payment/Insurance/Funding Accepted

• Medicare
• Private health insurance

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Detoxification
• Substance use treatment

Pharmacotherapies

• Clonidine
• Buprenorphine with naloxone
• Nicotine replacement
• Naltrexone (oral)
• Medication for mental disorders
• Non-nicotine smoking/tobacco cessation
• Disulfiram
• Acamprosate (Campral®)

License/Certification/Accreditation

• National Committee for Quality Assurance (NCQA)

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Education and Counseling Services

• Marital/couples counseling
• Smoking/vaping/tobacco cessation counseling
• Hepatitis education, counseling, or support
• Individual counseling
• Substance use disorder education
• Health education services other than HIV/AIDS or hepatitis
• Group counseling
• Family counseling

Treatment Approaches

• Substance use disorder counseling
• Trauma-related counseling
• Relapse prevention
• Motivational interviewing
• Cognitive behavioral therapy
• Telemedicine/telehealth therapy
• Anger management

Medical Services

• Hepatitis A (HAV) vaccination
• Hepatitis B (HBV) vaccination

Other Languages

• Farsi

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Language Services

• Other languages (excluding Spanish)
• Spanish
• Sign language services for the deaf and hard of hearing

Assessment/Pre-treatment

• Screening for substance use
• Screening for tobacco use
• Outreach to persons in the community
• Screening for mental disorders
• Comprehensive substance use assessment
• Comprehensive mental health assessment